FDA Approves New Long-Acting HIV Prevention Drug Offering Hope and Affordability
The FDA has approved lenacapavir, a groundbreaking injectable drug that offers near-complete protection against HIV with just two doses a year, representing a significant advancement in HIV prevention, though high costs and access issues remain challenges.